YOLFTbeta
Kedoya Adyaraya Tbk PT

Kedoya Adyaraya Tbk PT

RSGK · JK · Healthcare / Medical Care Facilities

955.00IDR+15.00 (+1.60%)

Price History

Full chart

Market Stats

Previous Close940.00
Open1,100.00
Day Range900.00 – 1,100.00
52-Week Range610.00 – 1,560.00
Volume7.20K
Market Cap966.86B
P/E (TTM)28.33
Forward P/E0.00
EPS36.71
Dividend Yield0.00%
Beta-0.64
50-Day Avg986.10
200-Day Avg1,025.58

About

PT Kedoya Adyaraya Tbk owns and operates hospitals in Indonesia. It offers facilities, such as inpatient and outpatient services; and healthcare services, and building and operating hospitals. The company was founded in 1990 and is headquartered in Jakarta, Indonesia. PT Kedoya Adyaraya Tbk is a subsidiary of PT Sarana Meditama Metropolitan Tbk.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEODr. Juniwati Gunawan M.M.
  • Employees794
  • HeadquartersJalan Panjang Arteri No.26, Jakarta, Indonesia, 11520, Indonesia
  • Websitehttps://www.grhakedoya.com

Leadership

  • Dr. Juniwati Gunawan M.M.President Director · b. 1963
  • Ms. Agnes Pricilia SuryantoHead of Internal Audit Unit · b. 1992
  • Agus RosyadiCorporate Secretary

Financials

Income Statement

Currency: IDR2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue242.99B284.70B294.92B435.20B359.16B373.40B441.07B469.59B
Growth (%)-+17.17%+3.59%+47.57%-17.47%+3.97%+18.12%+6.47%
Cost of Revenue160.41B188.66B193.45B251.13B227.21B232.50B291.75B332.93B
Gross Profit82.58B96.04B101.46B184.07B131.94B140.90B149.32B136.67B
Gross Margin33.98%33.73%34.40%42.30%36.74%37.73%33.85%29.10%
Operating Expense71.17B71.09B67.07B91.78B88.10B111.40B94.30B92.64B
Operating Income11.41B24.95B34.39B92.29B43.85B29.50B55.03B44.03B
Operating Margin4.70%8.76%11.66%21.21%12.21%7.90%12.48%9.38%
EBITDA43.55B53.28B60.97B121.83B73.84B62.43B67.44B83.09B
EBITDA Margin17.92%18.71%20.67%27.99%20.56%16.72%15.29%17.69%
Net Income12.72B3.94B2.62B52.91B26.18B25.19B39.69B34.51B
Net Income Margin5.24%1.38%0.89%12.16%7.29%6.75%9.00%7.35%
Interest Expense11.62B18.67B19.31B16.29B4.41B2.47B2.35B7.25B
Interest Expense % of Total Revenue4.78%6.56%6.55%3.74%1.23%0.66%0.53%1.54%

Balance Sheet

Currency: IDR2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets664.35B728.25B752.74B946.17B893.69B828.80B887.63B1.08T
Total Liabilities380.46B252.92B265.01B104.37B78.15B77.63B89.17B253.74B
Total Equity279.45B483.90B482.93B841.48B814.60B750.32B797.67B828.79B
Cash33.78B32.56B32.16B138.78B173.74B57.42B54.40B61.36B
Total Debt129.77B157.30B201.71B30.15B575.39M--21.00B
Net Debt95.99B124.74B169.56B-108.63B-173.17B-57.42B-54.40B-40.36B

Cash Flow

Currency: IDR2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow12.72B3.42B22.27B85.54B68.28B28.18B81.80B90.25B
Investing Cash Flow-75.45B-44.63B-22.03B-142.83B76.72B-54.67B-47.60B-90.24B
Financing Cash Flow41.54B39.99B-643.11M163.91B-110.03B-89.82B-37.23B6.96B
Capital Expenditure77.75B25.52B4.04B68.44B21.33B34.21B61.62B50.80B
Free Cash Flow-65.02B-22.11B18.23B17.11B46.95B-6.03B20.18B39.44B
Dividends Paid5.00B---79.95B89.25B10.23B0
FCF to OCF-511.09%-646.81%81.85%20.00%68.76%-21.40%24.67%43.71%
Dividend Paid to FCF-7.69%---170.31%-1479.59%50.67%0.00%

Earnings

Report DateDec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Mar 31, 2023
EPS Estimate-----
EPS Actual-18.1721.49-4.0623.4915.87
Surprise-----
Timing-----

Key Statistics & Ratios

Market Cap966.86B
Enterprise Value920.25B
Trailing P/E28.33
Forward P/E0.00
Price / Sales1.89
Price / Book1.14
EPS36.71
Book Value911.91
Revenue (TTM)511.62B
Gross Profit (TTM)155.31B
EBITDA97.85B
Profit Margin6.68%
Operating Margin10.38%
Return on Equity4.10%
Return on Assets3.11%
Shares Outstanding929.67M
Shares Float88.86M
Beta-0.64
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20241×
11.00Jun 24, 2024
20232×
15.00Aug 21, 202381.00Jun 22, 2023
20221×
86.00Jun 17, 2022